Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$249.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| Jun 18 | AGIO | Agios Pharmaceuticals,… | MEXER◆ | 2,816 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | AGIO | Agios Pharmaceuticals,… | MEXER | 2,816 | — | — | +35.0% | Open the original filing on SEC.gov |
| Jun 13 | AGIO | Agios Pharmaceuticals,… | MEXER◆ | 1,976 | — | — | — | Open the original filing on SEC.gov |
| Jun 13 | AGIO | Agios Pharmaceuticals,… | MEXER | 1,976 | — | — | +32.5% | Open the original filing on SEC.gov |
| Mar 25 | ACAD | Acadia Pharmaceuticals INC | SSELL◷? | 11,641 | $21.47 | $249.9K | -44.0% | Open the original filing on SEC.gov |
| Mar 24 | ACAD | Acadia Pharmaceuticals INC | MEXER◆ | 23,509 | — | — | — | Open the original filing on SEC.gov |
| Mar 24 | ACAD | Acadia Pharmaceuticals INC | MEXER | 23,509 | — | — | +801.0% | Open the original filing on SEC.gov |